Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.

Zhu C, Peng T, Huang D, Feng D, Wang X, Pan X, Tan W, Wu C.

AAPS PharmSciTech. 2019 Jan 9;20(2):64. doi: 10.1208/s12249-018-1208-8.

PMID:
30627822
2.

Comparative studies on exenatide-loaded poly (D,L-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying.

Zhu C, Huang Y, Zhang X, Mei L, Pan X, Li G, Wu C.

Colloids Surf B Biointerfaces. 2015 Aug 1;132:103-10. doi: 10.1016/j.colsurfb.2015.05.001. Epub 2015 May 11.

PMID:
26037698
3.

Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.

Qi F, Wu J, Fan Q, He F, Tian G, Yang T, Ma G, Su Z.

Colloids Surf B Biointerfaces. 2013 Dec 1;112:492-8. doi: 10.1016/j.colsurfb.2013.08.048. Epub 2013 Sep 7.

PMID:
24075786
4.

Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts.

Pascual-Gil S, Simón-Yarza T, Garbayo E, Prosper F, Blanco-Prieto MJ.

J Control Release. 2015 Dec 28;220(Pt A):388-396. doi: 10.1016/j.jconrel.2015.10.058. Epub 2015 Nov 9.

PMID:
26546270
5.

Impact of microparticle formulation approaches on drug burst release: a level A IVIVC.

Ishak RA, Mortada ND, Zaki NM, El-Shamy Ael-H, Awad GA.

J Microencapsul. 2014;31(7):674-84. doi: 10.3109/02652048.2014.913724. Epub 2014 Jun 25.

PMID:
24963960
6.

Incorporation of fast dissolving glucose porogens and poly(lactic-co-glycolic acid) microparticles within calcium phosphate cements for bone tissue regeneration.

Smith BT, Lu A, Watson E, Santoro M, Melchiorri AJ, Grosfeld EC, van den Beucken JJJP, Jansen JA, Scott DW, Fisher JP, Mikos AG.

Acta Biomater. 2018 Sep 15;78:341-350. doi: 10.1016/j.actbio.2018.07.054. Epub 2018 Aug 1.

PMID:
30075321
7.

Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System.

Huang Z, Chen X, Fu H, Wen X, Ma C, Zhang J, Wu C, Huang Y, Pan X, Wu C.

J Pharm Sci. 2017 Nov;106(11):3363-3371. doi: 10.1016/j.xphs.2017.07.010. Epub 2017 Jul 20.

PMID:
28736289
8.

Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.

Liu B, Dong Q, Wang M, Shi L, Wu Y, Yu X, Shi Y, Shan Y, Jiang C, Zhang X, Gu T, Chen Y, Kong W.

Chem Pharm Bull (Tokyo). 2010 Nov;58(11):1474-9.

9.

Development and Characterization of Olanzapine Loaded Poly(lactide-co-glycolide) Microspheres for Depot Injection: In Vitro and In Vivo Release Profiles.

Pervaiz F, Ahmad M, Murtaza G.

Curr Drug Deliv. 2018 Dec 26. doi: 10.2174/1567201816666181227105930. [Epub ahead of print]

PMID:
30588882
10.

Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.

Jiang Y, Wang F, Xu H, Liu H, Meng Q, Liu W.

Int J Pharm. 2014 Nov 20;475(1-2):475-84. doi: 10.1016/j.ijpharm.2014.09.016. Epub 2014 Sep 16.

PMID:
25219858
11.
12.

Exenatide-loaded PLGA microspheres with improved glycemic control: in vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats.

Xuan J, Lin Y, Huang J, Yuan F, Li X, Lu Y, Zhang H, Liu J, Sun Z, Zou H, Chen Y, Gao J, Zhong Y.

Peptides. 2013 Aug;46:172-9. doi: 10.1016/j.peptides.2013.06.005. Epub 2013 Jun 14.

PMID:
23770254
13.

PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.

Elsaid N, Jackson TL, Elsaid Z, Alqathama A, Somavarapu S.

Mol Pharm. 2016 Sep 6;13(9):2923-40. doi: 10.1021/acs.molpharmaceut.6b00335. Epub 2016 Jun 22.

PMID:
27286558
14.

An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.

Hu X, Zhang J, Tang X, Li M, Ma S, Liu C, Gao Y, Zhang Y, Liu Y, Yu F, Yang Y, Guo J, Li Z, Mei X.

Curr Drug Deliv. 2018;15(1):87-96. doi: 10.2174/1567201814666170516113406.

PMID:
28521697
15.

Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.

Vora L, V G S, Vavia P.

Eur J Pharm Sci. 2017 Sep 30;107:78-86. doi: 10.1016/j.ejps.2017.06.027. Epub 2017 Jun 16.

PMID:
28629804
16.

Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.

Wang H, Zhang G, Ma X, Liu Y, Feng J, Park K, Wang W.

Eur J Pharm Biopharm. 2017 Jun;115:177-185. doi: 10.1016/j.ejpb.2017.02.021. Epub 2017 Mar 2.

PMID:
28263795
17.

Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.

Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT, Shin BS, Lee KC, Youn YS.

Biomaterials. 2012 Aug;33(22):5574-83. doi: 10.1016/j.biomaterials.2012.04.018. Epub 2012 May 10.

PMID:
22579235
18.

[Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].

Li JL, Zheng CL, Liu JP, Zhu JB.

Yao Xue Xue Bao. 2013 May;48(5):759-66. Chinese.

PMID:
23888702
19.

Development of PLGA-based itraconazole injectable nanospheres for sustained release.

Bian X, Liang S, John J, Hsiao CH, Wei X, Liang D, Xie H.

Int J Nanomedicine. 2013;8:4521-31. doi: 10.2147/IJN.S54040. Epub 2013 Nov 21.

20.

PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.

Manca ML, Mourtas S, Dracopoulos V, Fadda AM, Antimisiaris SG.

Colloids Surf B Biointerfaces. 2008 Apr 1;62(2):220-31. Epub 2007 Oct 11.

PMID:
18023977

Supplemental Content

Support Center